ABOUT THIS EPISODE
The Podcast focuses on how technology, specifically augmented intelligence (AI), can improve the efficiency and compliance of drug development. The article emphasizes the importance of technology in streamlining back-office operations and supporting the regulatory aspects of Chemistry, Manufacturing, and Controls (CMC) for pharmaceutical companies. The text highlights how AI-powered solutions can automate processes, enhance collaboration, and provide data-driven insights to help companies navigate complex regulatory submissions. The article showcases Enkrisi, a company utilizing AI-powered solutions to revolutionize regulatory CMC, and presents their platform, EnkrisiGPT, as a cutting-edge solution for navigating the complexities of drug development.
